📰 Alector News
Page 2 - Alector News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alector. Real-time updates on events, politics, business and more.
October 14, 2023
Baillie Gifford & Co. trimmed its stake in shares of Alector, Inc. (NASDAQ:ALEC – Free Report) by 1.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 385,064 shares of the company’s stock after selling 5,049 shares during the quarter. Baillie Gifford & Co. […]
September 29, 2023
The Goldman Sachs Group assumed coverage on shares of Alector (NASDAQ:ALEC – Free Report) in a research note released on Monday, MarketBeat.com reports. The firm issued a sell rating and a $4.00 price target on the stock. ALEC has been the subject of a number of other reports. Cantor Fitzgerald started coverage on Alector in […]
September 25, 2023
Alector, Inc. (ALEC.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alector, Inc. | Nasdaq: ALEC | Nasdaq
September 25, 2023
Alector, Inc. (NASDAQ:ALEC – Get Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $6.88, but opened at $6.23. Alector shares last traded at $6.21, with a volume of 817,012 shares traded. Analysts Set New Price Targets ALEC has been the topic of several recent research […]
September 22, 2023
Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $6.03, but opened at $6.34. Alector shares last traded at $6.46, with a volume of 179,704 shares traded. Wall Street Analysts Forecast Growth Several brokerages have commented on ALEC. Mizuho dropped […]
September 8, 2023
Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have been given an average rating of “Moderate Buy” by the seven ratings firms that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average […]
August 26, 2023
Alector (NASDAQ:ALEC – Get Free Report) and Genocea Biosciences (NASDAQ:GNCAQ – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk. Risk and Volatility Alector has a beta of […]
August 14, 2023
Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price […]
August 12, 2023
Alector (NASDAQ:ALEC – Free Report) had its price objective cut by Mizuho from $12.00 to $10.00 in a report released on Friday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock. ALEC has been the subject of a number of other reports. Stifel Nicolaus lowered their price objective on shares of […]
August 9, 2023
Alector, Inc. (NASDAQ:ALEC – Free Report) – Analysts at William Blair issued their Q1 2024 EPS estimates for Alector in a note issued to investors on Friday, August 4th. William Blair analyst M. Minter anticipates that the company will post earnings per share of ($0.71) for the quarter. The consensus estimate for Alector’s current full-year […]